NASDAQ:IKNA
Ikena Oncology, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Marketwebsite
ikenaoncology.comipo date
Mar 26, 2021full time employees
80currency
USD
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibit...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus